Announcements
- NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE BREVET AUX ÉTATS-UNIS DÉDIÉE À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL AVEC NFL-301 & PRÉPARATION D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDA
- Nfl Biosciences: Patent Application Filed in the United States for Reducing Alcohol Consumption With Nfl-301 & Preparation of a Pre-Ind Application Submission With the Fda
- NFL BIOSCIENCES CONFIRME LE RENOUVELLEMENT DE SON ELIGIBILITE AU PEA-PME
- BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ : 1er SEMESTRE 2023
Key statistics
On Friday, Nfl Biosciences SAS (82F:FRA) closed at 2.73, -8.54% below its 52-week high of 2.99, set on Aug 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.73 |
---|---|
High | 2.73 |
Low | 2.73 |
Bid | 2.60 |
Offer | 2.82 |
Previous close | 2.45 |
Average volume | 0.00 |
---|---|
Shares outstanding | 9.71m |
Free float | 7.28m |
P/E (TTM) | -- |
Market cap | 26.01m EUR |
EPS (TTM) | -0.5396 EUR |
Data delayed at least 15 minutes, as of Jul 05 2024 07:02 BST.
More ▼